Essential Medicines Strategic Stockpile Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 28, 2021)
Essential Medicines Strategic Stockpile Act of 2021
This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
What just happenedApr 29, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 28, 2021
- Apr 29, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 28, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 28, 2021IntroReferralIntro-H
Introduced in House
- Apr 28, 2021IntroReferral1000
Introduced in House